Clinical Trials Logo

Clinical Trial Summary

This study is being conducted to evaluate the safety and efficacy of a fractional diode laser for treatment of pigmented lesions such as, but not limited to lentigos (age spots), solar lentigos (sunspots), and ephelides (freckles).


Clinical Trial Description

Prospective, open-label, clinical trial to study the effects of the nonablative, fractional diode laser for treatment of pigmented lesions. Up to 60 eligible participants will be enrolled at up to five (5) sites. Participants will receive up to three (3) treatments in the following treatment areas: face, hands, arms, back, chest, or legs. Participants will complete follow-up visits for clinical evaluation and photography at 1 and 3 months after the final study treatment. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04202419
Study type Interventional
Source Candela Corporation
Contact
Status Completed
Phase N/A
Start date January 9, 2020
Completion date April 26, 2021

See also
  Status Clinical Trial Phase
Completed NCT02613325 - fPAM for the in Vivo Depth Measurement of Pigmented Lesions and Melanoma Depth Phase 1
Completed NCT02848742 - Dermal Cryotherapy for Treatment of Pigmented Lesions N/A
Enrolling by invitation NCT04566302 - Pilot Study of Imaging Human Skin With High-Speed Spectrally Encoded Confocal Microscopy N/A
Recruiting NCT06263413 - Clinical Workflow Optimization Using Artificial Intelligence for Dermatological Conditions
Recruiting NCT03362138 - Artificial Intelligence-assisted Evaluation of Pigmented Skin Lesions